The trademark application ONEZEROMED was filed by Merck KGaA, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on July 16, 2020, and it was registered by office on October 26, 2020 without any oppositions.
It was designated 'Basic Application' for International Application null at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).